InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal
In this InvestorIntel interview, Dr. Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. (TSXV: IGX |OTCQX: IGXT), discusses the recent deal with Eli Lilly to manufacture Tadalafil (also known as Cialis®) as a pharmaceutical oral film, using IntelGenx’s VersaFilm™ technology. IntelGenx’s tadalafil oral film offers an improved discrete dosage form that does not require water intake. Dr. Zerbe states that this deal is significant because moving forward potential partner licensees will not face any litigation after completing a deal with IntelGenx, making the launch and commercialization of a VersaFilm™ partnered product extremely easy…to access the complete interview, click here
Disclaimer: IntelGenx Technologies Corp. is an advertorial member of InvestorIntel Corp.
Get our daily investorintel update
InvestorIntel is a trusted source of reliable information at the forefront of emerging markets that brings investment opportunities to discerning investors.